Revenue for the six months ended June 30, 2026 was USD 1,988,604 against none for the same period in 2025. The filing states that it came from newly acquired subsidiaries Pacific Sun Packaging, AGA Precision Systems, SVM Machining and A&B Aerospace, none of which …
SeaStar is a commercial stage healthcare company focused on treatments for critically ill patients facing organ failure. Its Selective Cytopheretic Device is designed to neutralize over-active immune cells and address hyperinflammation.
The company describes itself as a strategic acquirer and operator of aerospace and defense businesses. It is building a portfolio of mission-critical suppliers and advanced technology companies across defense, aerospace and advancedManufacturingin the United States, Israel and Europe.
Vyome is a clinical stage biopharmaceutical company focused on immuno inflammatory and rare disease conditions.
Capital International Investors filed an amended beneficial ownership statement with the SEC on November 5, 2026, disclosing a 10.3% stake in Aurora Innovation, Inc. (NASDAQ:AUR) as of the event date of October 30, 2026.
Great Southern Bancorp, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 6, 2026, reporting third-quarter net income of $14.009 million and total assets of $5.821 billion.
Unilever PLC officer Fabian T. Garcia filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 32,000 American Depositary Shares on the New York Stock Exchange through Fidelity Brokerage Services LLC.
Director Robert M. Brill filed a Form 4 with the SEC on November 6, 2026, disclosing an automatic grant of 11,100 shares of CVD Equipment Corp common stock on November 5, 2026, the date of the company's 2026 Annual Meeting of Shareholders.
Director Anne DelSanto filed a Form 4 with the SEC on November 6, 2026, reporting the sale of 265 shares of Advanced Energy Industries Inc common stock on November 5, 2026, under a pre-established Rule 10b5-1 trading plan.
Ellington Financial Inc. filed its Form 10-Q with the SEC on November 6, 2026, reporting unaudited condensed consolidated financial results for the quarterly and nine-month periods ended September 30, 2026.